现场调查员：分子诊断学的优势与劣势。
SURVEYOR on the spot: strengths and weaknesses in molecular diagnostics.
出版信息
J Mol Diagn. 2010 Mar;12(2):265; author reply 265-6. doi: 10.2353/jmoldx.2010.090193.
Abstract
This correspondence addresses J Mol Diagn 2009, 11:311–318, on the advantages and disadvantages of using SURVEYOR in molecular diagnostic mutation detection.
摘要
这封通信是关于《J Mol Diagnostics》2009 年第 11 期第 311-318 页的，内容涉及在分子诊断突变检测中使用 SURVEYOR 的优缺点。
相似文献
1
SURVEYOR on the spot: strengths and weaknesses in molecular diagnostics.现场调查员：分子诊断学的优势与劣势。
J Mol Diagn. 2010 Mar;12(2):265; author reply 265-6. doi: 10.2353/jmoldx.2010.090193.
2
[Molecular genetic methods used in diagnosis of hereditary cancers].[用于遗传性癌症诊断的分子遗传学方法]
Magy Onkol. 2020 Mar 17;64(1):25-31. Epub 2020 Feb 2.
3
[The cutting-edge of medicine; genetic diagnosis for hypertrophic cardiomyopathy: how to promote its clinical application].[医学前沿；肥厚型心肌病的基因诊断：如何促进其临床应用]
Nihon Naika Gakkai Zasshi. 2013 May 10;102(5):1233-42. doi: 10.2169/naika.102.1233.
4
Genotyping with TaqMAMA.采用TaqMAMA进行基因分型。
Genomics. 2004 Feb;83(2):311-20. doi: 10.1016/j.ygeno.2003.08.005.
5
Developments in molecular genetic diagnostics: an update for the pediatric epilepsy specialist.分子遗传诊断学的进展：儿科癫痫专家的最新资讯。
Pediatr Neurol. 2011 May;44(5):317-27. doi: 10.1016/j.pediatrneurol.2011.01.017.
6
Advances in genetic diagnostics for hereditary hearing loss.遗传性听力损失的基因诊断进展。
J Basic Clin Physiol Pharmacol. 2013;24(3):165-70. doi: 10.1515/jbcpp-2013-0063.
7
Molecular screening for the Lynch syndrome--better than family history?林奇综合征的分子筛查——比家族史更好吗？
N Engl J Med. 2005 May 5;352(18):1920-2. doi: 10.1056/NEJMe058058.
8
Molecular pathology diagnostics in cutaneous mesenchymal tumors.皮肤间叶性肿瘤的分子病理学诊断
J Dtsch Dermatol Ges. 2013 May;11 Suppl 4:36-49. doi: 10.1111/ddg.12086_supp.
9
Surveyor nuclease-based detection of p53 gene mutations in haematological malignancy.基于Surveyor核酸酶检测血液系统恶性肿瘤中的p53基因突变
Ann Clin Biochem. 2007 Nov;44(Pt 6):557-9. doi: 10.1258/000456307782268174.
10
Leveraging digital pathology for molecular testing.利用数字病理学进行分子检测。
Cancer Cytopathol. 2018 Dec;126(12):965-966. doi: 10.1002/cncy.22062. Epub 2018 Oct 14.
本文引用的文献
1
Screening for mutations in kidney-related genes using SURVEYOR nuclease for cleavage at heteroduplex mismatches.使用Surveyor核酸酶在异源双链错配处进行切割，以筛选肾脏相关基因中的突变。
J Mol Diagn. 2009 Jul;11(4):311-8. doi: 10.2353/jmoldx.2009.080144. Epub 2009 Jun 12.
2
Mutation analysis in nephronophthisis using a combined approach of homozygosity mapping, CEL I endonuclease cleavage, and direct sequencing.采用纯合性定位、CEL I核酸内切酶切割和直接测序相结合的方法对肾单位肾痨进行突变分析。
Hum Mutat. 2008 Mar;29(3):418-26. doi: 10.1002/humu.20669.
3
Screening human genes for small alterations performing an enzymatic cleavage mismatched analysis (ECMA) protocol.采用酶切错配分析（ECMA）方案筛选人类基因中的微小改变。
Mol Biotechnol. 2007 Nov;37(3):212-9. doi: 10.1007/s12033-007-0065-6. Epub 2007 Aug 3.
4
Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome.人类IV型胶原基因COL4A3的结构与常染色体隐性遗传性阿尔波特综合征中的突变
J Am Soc Nephrol. 2001 Jan;12(1):97-106. doi: 10.1681/ASN.V12197.
Zotero 插件